Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 4.000% 4/0
-
Number of holders
-
4
-
Total 13F principal, excl. options
-
99.7M
-
Principal change
-
+15K
-
Total reported value, excl. options
-
$78.3M
-
Value change
-
+$13K
-
Number of buys
-
1
-
Price
-
$0.86
Significant Holders of TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q4 2021
4 filings reported holding 89643QAB4 - TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q4 2021.
TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 has 4 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $99.7M of principal
.
Largest 4 bondholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC ($53.2M of principal), STONEHILL CAPITAL MANAGEMENT LLC ($39.5M of principal), Whitefort Capital Management, LP ($7M of principal), and ROYAL BANK OF CANADA ($15K of principal).
This table shows the top 4 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.